Evidence map›Paper›PMID 24129700›Full record

ArticleScience signaling2013

Using functional signature ontology (FUSION) to identify mechanisms of action for natural products.

Malia B Potts, Hyun Seok Kim, Kurt W Fisher, Youcai Hu, Yazmin P Carrasco, Gamze Betul Bulut, Yi-Hung Ou, Mireya L Herrera-Herrera, Federico Cubillos, Saurabh Mendiratta and 8 more

Open access · greenAbstract read
In one paragraph

Article in Science signaling, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 73 citations in OpenAlex.

  1. Review
  2. Modulation ofJournal of natural products · 2023
    Article
  3. Review
  4. Article
  5. High-throughput functional annotation of natural products by integrated activity profiling.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Structure, Function, and Regulation of the SRMS Tyrosine Kinase.International journal of molecular sciences · 2020
    Review
  14. Review
  15. Article
  16. Improving natural product research translation: From source to clinical trial.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 1 country.

Malia B Potts1Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
Hyun Seok Kim
Kurt W Fisher
Youcai Hu
Yazmin P Carrasco
Gamze Betul Bulut
Yi-Hung Ou
Mireya L Herrera-Herrera
Federico Cubillos
Saurabh Mendiratta
Guanghua Xiao
Matan Hofree
Trey Ideker
Yang Xie
Lily Jun-shen Huang
Robert E Lewis
John B MacMillan
Michael A White
The University of Texas Southwestern Medical Center · USUniversity of Nebraska Medical Center · US

Funding

UNMC/EPPLEY CANCER CENTER SUPPORT GRANTP30CA036727 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Apar Kishor Ganti · 1985 to 2026
$55.0M
UT Southwestern Medical Center Simmons Comprehensive Cancer CenterP30CA142543 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI Sandi Leigh Pruitt · 2010 to 2026
$53.7M
TR&D 3 - Network Guided Machine LearningP41GM103504 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI IDEKER, TREY · 2012 to 2024
$17.3M
Cancer Biology Training GrantT32CA124334 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI SHAY, JERRY WILLIAM · 2007 to 2021
$5.3M
COMPONENTS OF RAS-MEDIATED GROWTH CONTROLR01CA071443 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI WHITE, MICHAEL A. · 1996 to 2015
$4.8M
Lung cancer oncogenotype-selective drug target discoveryU01CA176284 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI MACMILLAN, JOHN B, MINNA, JOHN D. · 2013 to 2016
$2.8M
KSR, a Modifier of Ras-Mediated Cell TransformationR01CA090400 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI LEWIS, ROBERT E. · 2002 to 2012
$2.7M
Marine Actinomycetes as a Resource for Anticancer Natural ProductsR01CA149833 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI MACMILLAN, JOHN B · 2010 to 2014
$1.6M
Novel Effectors of Colon TumorigenesisR01CA157774 · NCI · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI LEWIS, ROBERT E. · 2012 to 2016
$1.5M
Predicting Adjuvant Chemotherapy Response in Lung CancerR01CA152301 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI XIE, YANG · 2010 to 2014
$1.5M
The RaLGTPase Regulatory NetworkR01CA129451 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI WHITE, MICHAEL A. · 2007 to 2011
$1.3M
NCI NIH HHS CA071443NCI NIH HHS CA129451NCI NIH HHS CA149833NCI NIH HHS CA152301NCI NIH HHS CA157774NCI NIH HHS CA90400NCI NIH HHS P30 CA036727NCI NIH HHS P30 CA142543NCI NIH HHS R01 CA071443NCI NIH HHS R01 CA090400NCI NIH HHS R01 CA129451NCI NIH HHS R01 CA149833NCI NIH HHS R01 CA152301NCI NIH HHS R01 CA157774NCI NIH HHS T32 CA124334NCI NIH HHS U01 CA176284NIGMS NIH HHS P41 GM103504
6 · The paper itself

Abstract

A challenge for biomedical research is the development of pharmaceuticals that appropriately target disease mechanisms. Natural products can be a rich source of bioactive chemicals for medicinal applications but can act through unknown mechanisms and can be difficult to produce or obtain. To address these challenges, we developed a new marine-derived, renewable natural products resource and a method for linking bioactive derivatives of this library to the proteins and biological processes that they target in cells. We used cell-based screening and computational analysis to match gene expression signatures produced by natural products to those produced by small interfering RNA (siRNA) and synthetic microRNA (miRNA) libraries. With this strategy, we matched proteins and miRNAs with diverse biological processes and also identified putative protein targets and mechanisms of action for several previously undescribed marine-derived natural products. We confirmed mechanistic relationships for selected siRNAs, miRNAs, and compounds with functional roles in autophagy, chemotaxis mediated by discoidin domain receptor 2, or activation of the kinase AKT. Thus, this approach may be an effective method for screening new drugs while simultaneously identifying their targets.

Indexed as

Gene OntologyAnimalsAutophagyBacteriaBiological ProductsCell Line, TumorCells, CulturedCluster AnalysisComputational BiologyDrug Evaluation, PreclinicalGene Expression Regulation, NeoplasticGene Regulatory NetworksHCT116 CellsHumansInvertebratesMarine BiologyBiological ProductsMicroRNAs

Identifiers

PMID24129700
PMCPMC4075427
OpenAlexW2063890235

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.